
Christiaan W Schiepers MD PhD
Professor, Molecular & Medical Pharmacology, University of California
Join to View Full Profile
200 UCLA Medical PlzSuite B114Los Angeles, CA 90095
Phone+1 310-983-1439
Fax+1 310-206-4899
Are you Dr. Schiepers?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christiaan Schiepers, MD is a board certified nuclear medicine physician in Los Angeles, California. He is currently licensed to practice medicine in California. He is a Professor at University of California.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 1989 - 1990
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Nuclear Medicine, 1987 - 1989
- Albany Medical CenterFellowship, Cardiovascular Disease, 1986 - 1987
- Albany Medical CenterResidency, Internal Medicine, 1984 - 1986
- Utrecht University Faculty of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 1988 - 2026
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- 9 citationsQuantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer.Matthew S. Brown, Grace Kim, Gregory H. Chu, Bharath Ramakrishna, Martin Allen-Auerbach
Journal of Medical Imaging. 2018-01-11 - 24 citationsMost of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.Jeremie Calais, Johannes Czernin, Matthias Eiber, Wolfgang P. Fendler, Jeannine Gartmann
Journal of Nuclear Medicine. 2017-05-04 - 18 citationsHuman Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway.Martin Barrio, Claudio Spick, Caius G. Radu, Michael Lassmann, Uta Eberlein
Journal of Nuclear Medicine. 2017-03-01
Press Mentions
- Newly Developed PSG Score Improves Patient Selection for PSMA Radiopharmaceutical TherapyApril 20th, 2023